Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 5.175.104.845.359.40

What is the latest Working Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Working Capital/Sales ratio of AUROBINDO PHARMA is 5.17 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20245.17
Mar20235.10
Mar20224.84
Mar20215.35
Mar20209.40

How is Working Capital/Sales of AUROBINDO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 5.17
1.37
Mar2023 5.1
5.37
Mar2022 4.84
-9.53
Mar2021 5.35
-43.09
Mar2020 9.4 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Working Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses